ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer ☆
Titel:
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer ☆
Auteur:
Planchard, D. Reinmuth, N. Orlov, S. Fischer, J.R. Sugawara, S. Mandziuk, S. Marquez-Medina, D. Novello, S. Takeda, Y. Soo, R. Park, K. McCleod, M. Geater, S.L. Powell, M. May, R. Scheuring, U. Stockman, P. Kowalski, D.